Warnings without guidance: patient responses to an FDA warning about ezetimibe.
Shrank WH, Choudhry NK, Tong A, Myers J, Fischer MA, Swanton K, Slezak J, Brennan TA, Liberman JN, Moffit S, Avorn J, Carpenter D.
Shrank WH, et al.
Med Care. 2012 Jun;50(6):479-84. doi: 10.1097/MLR.0b013e31825517b6.
Med Care. 2012.
PMID: 22581012